Founded 2019 · HQ: Ireland
Medtronic's Hugo RAS is a modular robotic surgical system competing directly with da Vinci, with CE mark approval and commercial launch across Europe and Latin America.
Medtronic Hugo holds the #3 position in the category with an automation score of 4.5, determined by a composite of R&D investment, AI patent filings, and operational fleet metrics.
With an annual R&D commitment of $0.55 billion and 420 filed patents, Medtronic Hugo is a top-tier player in the global landscape. The company is headquartered in Ireland, one of the world's leading automation economies.
🔍 Data Provenance
Last verified: Q1 2026 (February)
Sources: Medtronic 10-K FY2025; EPO; MDT investor presentations
Figures are research-backed estimates verified quarterly. R&D spend accurate to ±10%; patent counts vary by registry. Full methodology →
Want the full dataset on Medtronic Hugo?
Upgrade to Pro for CSV access
→